HEALOME Trademark

Trademark Overview


On Monday, February 27, 2023, a trademark application was filed for HEALOME with the United States Patent and Trademark Office. The USPTO has given the HEALOME trademark a serial number of 79377294. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, July 9, 2024. This trademark is owned by Healome Therapeutics Ltd. The HEALOME trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for; pharmaceutical preparations, substances and treatments used for treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances, namely, for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels for ; therapeutic gels for ; gel and liquid drops, sprays, films for , suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions in the nature of , and liquids for...

Scientific and technological services and research and design relating thereto, namely, ; industrial analysis and research services in the fields of ; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes in the fields of ; medical and bioscience research services in the fields of ; biomedical research services; surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therap...
healome

General Information


Serial Number79377294
Word MarkHEALOME
Filing DateMonday, February 27, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for; pharmaceutical preparations, substances and treatments used for treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances, namely, for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels for ; therapeutic gels for ; gel and liquid drops, sprays, films for , suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions in the nature of , and liquids for the treatment of ocular diseases and conditions; gels, suspensions, liquids and lubricants for the treatment of eye conditions and diseases; tear film substitutes for the treatment of ocular conditions; tear film substitutes for the treatment of eye conditions and diseases; gels, suspensions in the nature of , liquids and lubricants for the treatment of eye conditions, namely, glaucoma, cataracts, amblyopia, age-related macular degeneration and diabetes-related retinopathy; gels, suspensions, and liquids for medical and therapeutic use; eye drops; eye ointment; eye-washes; eye lotions for medical use; lubricating eye drops; liquid for the treatment of ocular diseases and conditions; ocular lubricants; tear film substitutes; tear substitutes for ocular diseases and conditions; tear film substitutes, namely, for ocular diseases and conditions
Goods and ServicesScientific and technological services and research and design relating thereto, namely, ; industrial analysis and research services in the fields of ; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes in the fields of ; medical and bioscience research services in the fields of ; biomedical research services; surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therapeutic research services; advisory, consultancy and information services relating to all the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 25, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHealome Therapeutics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 24, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, October 31, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 31, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 31, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2023ASSIGNED TO EXAMINER
Monday, December 4, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2023REFUSAL PROCESSED BY MPU
Wednesday, January 3, 2024REFUSAL PROCESSED BY IB
Tuesday, June 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 9, 2024FINAL REFUSAL WRITTEN
Tuesday, July 9, 2024FINAL REFUSAL E-MAILED
Tuesday, July 9, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 8, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 5, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW